Our reperfusion sets are fully CE-certified and approved for 30 days of continuous use.

Two CARL Controllers were donated to the Kyiv Heart Institute and have now been used for the first time – with great success.

CARL. has won the prestigious Prix Galien USA 2025 Award, widely regarded as the “Nobel Prize of biopharmaceutical research”.

Together with Dr. Tom Lines, we are broadening our research and development capabilities.

For the first time at St. Antonius Hospital in Kleve, a CARL system was used on a critically ill patient with acute cardiac arrest.

We are excited to share the new video that illustrates our vision for the chain of survival in out-of-hospital cardiac arrest (OHCA).

EMCrit Wee – Controlled Automated Reperfusion of the Whole Body (CARL) ECPR / ECLS Yields Amazing Result

The 12th Congress of the European Extracorporeal Life Support Organization (EuroELSO) takes place in Kraków, Poland at the ICE Kraków Congress Centre from 24th April to 27th April 2024. Meet CARL and our team to explore “advanced ECPR” for improving neurologically intact survival after refractory cardiac arrest.

It can happen to anyone at any time. Sudden cardiac arrest. The SWR-health programme ‘Doc Fischer’ explains the causes of sudden cardiac arrest, patient prevention possibilities and how the new second-line therapy CARL might improve survival rates further, both in- and out-of-hospital.

Image: SWR

Resuscitec GmbH is one of the 2023 winners of the German Business Awards at EU Business News.